Whittaker, HT;
Qui, Y;
Bettencourt, C;
Houlden, H;
(2017)
Multiple system atrophy: genetic risks and alpha-synuclein mutations.
F1000Research
, 6
, Article 2072. 10.12688/f1000research.12193.1.
Preview |
Text
55983c4b-ad3d-4af4-ab13-91ac0506b453_12193_-_Henry_Houlden.pdf - Published Version Download (1MB) | Preview |
Abstract
Multiple system atrophy (MSA) is one of the few neurodegenerative disorders where we have a significant understanding of the clinical and pathological manifestations but where the aetiology remains almost completely unknown. Research to overcome this hurdle is gaining momentum through international research collaboration and a series of genetic and molecular discoveries in the last few years, which have advanced our knowledge of this rare synucleinopathy. In MSA, the discovery of α-synuclein pathology and glial cytoplasmic inclusions remain the most significant findings. Families with certain types of α-synuclein mutations develop diseases that mimic MSA, and the spectrum of clinical and pathological features in these families suggests a spectrum of severity, from late-onset Parkinson's disease to MSA. Nonetheless, controversies persist, such as the role of common α-synuclein variants in MSA and whether this disorder shares a common mechanism of spreading pathology with other protein misfolding neurodegenerative diseases. Here, we review these issues, specifically focusing on α-synuclein mutations.
Type: | Article |
---|---|
Title: | Multiple system atrophy: genetic risks and alpha-synuclein mutations |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.12688/f1000research.12193.1 |
Publisher version: | http://doi.org/10.12688/f1000research.12193.1 |
Language: | English |
Additional information: | © 2017 Whittaker HT et al. This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication). |
Keywords: | MSA, multiple system atrophy, neurodegenerative disorders, α-synuclein |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery.ucl.ac.uk/id/eprint/10044542 |
Archive Staff Only
View Item |